Detalhe da pesquisa
1.
Bezlotoxumab during the first episode of Clostridioides difficile infection in patients at high risk of recurrence.
Eur J Clin Microbiol Infect Dis
; 43(3): 533-540, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236366